A Cross-Sectional Observational Study on Retained Drug Needle Fragments in People Who Use Intravenous Drugs

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorTampere University Hospital

About this trial

In addition to the well-known toxicological harms of intravenous drug (IVD) use, there can also be local tissue complications, including infections, venous sclerosis, tissue necrosis, and drug needle fragment retentions. Drug needle fragments in subcutaneous tissue may cause local symptoms (usually pain and infections), but they have also been identified as causing emboli to organs. The literature has described numerous case reports of people who inject drugs (PWIDs) and have retained needle fragments. The prevalence of the condition is not known, and the researchers therefore aim to perform the first cross-sectional study of PWIDs to estimate how common needle fragment retentions are and what their risk factors are in this population.

Eligibility criteria

Qualifiers

History of intravenous drug use

Current treatment of the drug abuse problem at a local low-threshold drug abuse service unit or primary health care centre.

Adherence to fill in the questionnaire

Participation to X-ray imaging of injection sites

Disqualifiers

No history of intravenous drug use

Does not adhere to fill in the questionnaire or refuses X-ray imaging

Pregnancy

Underage (18 years old)

Trial design

Treatments tested in this trial

  • Low-dose X-ray of subcutaneous tissues

Treatment groups

100 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Tampere University Hospital

Lead sponsor

Deaconess Foundation

Collaborator

A-Clinic Foundation

Collaborator